Emphasizing this point is the recent discovery of toxic gain of function resulting from prolonged overexpression of survival motor neuron protein (SMN) in the course of gene therapy for spinal muscular atrophy (78). The gene discussed is SNRPN; the disease is proximal spinal muscular atrophy.